Description:
CITRULLINEMIA, CLASSIC
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Disorders of the Urea Cycle |
Class |
Disorders of Amino Acid Metabolism |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
6 |
|
argininosuccinate synthase |
According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 6.3.4.5 |
|
Remarks |
Neonatal; deficient Argininosuccinate synthetase; no detectable enzyme antigen |
Si EC, Pfeifer RW, Yim GK, Iodoacetic acid and related sulfhydryl reagents fail to inhibit cell- cell communication: mechanisms of immunotoxicity in vitro. Toxicology44:73-89 1987 |
PubMed ID: 3105120 |
|
Su TS, Bock HG, Beaudet AL, O'Brien WE, Molecular analysis of argininosuccinate synthetase deficiency in human fibroblasts. J Clin Invest70:1334-9 1982 |
PubMed ID: 7174798 |
|
Cathelineau L, Dinh DP, Briand P, Kamoun P, Studies on complementation in argininosuccinate synthetase and argininosuccinate lyase deficiencies in human fibroblasts. Hum Genet57:282-4 1981 |
PubMed ID: 7250970 |
dbSNP |
dbSNP ID: 16037 |
NCBI GTR |
215700 CITRULLINEMIA, CLASSIC |
OMIM |
215700 CITRULLINEMIA, CLASSIC |
Omim Description |
ARGININOSUCCINATE SYNTHETASE DEFICIENCY; ASS DEFICIENCYARGININOSUCCINATE SYNTHETASE, INCLUDED; ASS, INCLUDED |
|
ARGININOSUCCINATE SYNTHETASE PSEUDOGENE 2, INCLUDED; ASSP2, INCLUDED |
|
ASSP4, INCLUDED |
|
ASSP5, INCLUDED |
|
ASSP6, INCLUDED |
|
CITRULLINEMIA |
|
CITRULLINURIA |
Passage Frozen |
6 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|